Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2000
10/05/2000CA2368376A1 50 human secreted proteins
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368234A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2368014A1 Casb619 involved in colon cancers
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365297A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2364417A1 Peroral gene therapy of diabetes and obesity
10/05/2000CA2363716A1 49 human secreted proteins
10/05/2000CA2329261A1 Susceptibility to psoriasis
10/04/2000EP1041152A1 Retroviral vectors
10/04/2000EP1041147A2 Microtubule-associated protein TPX2
10/04/2000EP1041146A1 Tumor antigen protein, gene thereof, and utilization thereof
10/04/2000EP1041144A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/04/2000EP1041142A2 Universal donor cells
10/04/2000EP1040835A2 Use of HST-1 in preventing and/or treating tissue damage in cancer therapy
10/04/2000EP1040198A1 Recombinant rhabdovirus containing a heterologous fusion protein
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040189A1 Polypeptides, their production and use
10/04/2000EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy
10/04/2000EP1040183A1 Nucleic acid encoding mammalian ubr1
10/04/2000EP1040126A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
10/04/2000EP1040125A1 Glucose regulated gene
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1039934A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039927A1 UGC (UPSTREAM GENE OF cdsA)
10/04/2000EP1039926A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
10/04/2000EP0821583B1 Dna vaccines against rotavirus infections
10/04/2000CN1057121C Method for prepn. of DNA elements for inhibiting growth of non-cancer cells
10/04/2000CN1057118C Recombinant C140 receptor
10/03/2000US6127598 Model with disruption of gene caused by insertion of a transgene; causes decreased level of insulin production and decreased number of insulin-producing cells; for drug screening
10/03/2000US6127525 Coat protein having non-native, non-hexon amino acid sequence; allows decreased ability or inability to be recognized by neutralizing antibodies against wild-type protein; for gene therapy
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127345 Utilizing glucose 6-phosphate dehydrogenase gene polypeptide for the protection against infection, particularly bacterial infections
10/03/2000US6127344 Polynucleotide immunogenic agents
10/03/2000US6127332 Muteins of IFN-β
10/03/2000US6127172 Transforming cells by introducing into in vitro cell an amount of recombinant entomopox virus vector which includes polynucleotide which encodes desired protein linked to an early promoter sequence; gene therapy using large inserts
10/03/2000US6127170 Multifunctional complexes for gene transfer into cells comprising a nucleic acid bound to a polyamine and having a endosome disruption agent
10/03/2000US6127147 Sensor histidine kinase of Staphylococcus Aureus
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126964 Making a complex for delivery to a cell, forming a polymer from monomers in the presence of polyion for delivery to cells
10/03/2000US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques.
10/03/2000US6126936 Microcapsules and composite microreactors for immunoisolation of cells
09/2000
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056924A2 Genomic sequence of the purh gene and purh-related biallelic markers
09/28/2000WO2000056915A1 Ispa from streptococcus pneumoniae
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056909A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056898A1 Immortal microvascular endothelial cells and uses thereof
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056884A1 pksG
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056871A2 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN α-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056764A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000WO2000056756A2 Prolactin regulatory element binding protein and uses thereof
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056753A1 49 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056748A1 Xylo-lna analogues
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056368A1 Gene therapeutics
09/28/2000WO2000056351A2 Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
09/28/2000WO2000056288A1 Nanoparticles, complexes with polynucleotides and their use
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000042972A3 Compositions and methods for intraductal gene therapy
09/28/2000WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000021559A3 Blocking factor b to treat complement-mediated immune disease
09/28/2000WO2000018796A3 Secretory protein- zsig48
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000012118A9 Inhibiting cardiomyocyte death
09/28/2000CA2377383A1 Apoptosis related genes
09/28/2000CA2368916A1 49 human secreted proteins
09/28/2000CA2368672A1 Genomic sequence of the purh gene and purh-related biallelic markers
09/28/2000CA2368548A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 870